- August 2, 2022
NASA Misses Another Opportunity to Explain Itself
Keith’s update: I just listened to Ken Savin, the Eli Lilly representative being interviewed at the International Space Station Research and Development Conference (ISSRDC). Lilly has 4 experiments that will fly on the ISS next year. I listened to this while I was out in the woods walking. These experiments are all very basic, clear-cut and rather elegant – so much so that I came up with a parallel classroom experiment for each instantly – and I am not especially talented in that regard. Savin said that he wished there was an organization to coordinate among companies to share data and information. Gee, I thought CASIS was supposed to do this. Savin was then asked if there was some sort of database where data and ISS research results were posted. He said “I am told there is one” and that someone just sent him a link to it. I am baffled as to why CASIS could not send him this stuff earlier in the process.
Savin said that his company does not plan to make drugs in space and that they are really doing these experiments to learn. That is a rather cool thing for a large multinational pharmaceutical company to say about using the ISS. It ought to be on a NASA bumper sticker. I did a quick Google search for “Eli Lilly CASIS” and only came up with a few article links – all of them inside the space community. A search for “Eli Lilly NASA” only found a few more links.
With all the moaning and groaning and self-loathing evidenced by NASA and others at the ISSRDC about not having told the public about what they are doing and why, that someone would have flagged this sort of activity and built a much larger education and public outreach effort for it. But no. NASA and CASIS would rather complain about not being able to do this than actually trying to do it.